GENEVA--Health experts fear that anti-flu drugs out in the market might not be able to readily cure the H1N1 virus if it mutates or changes its organism appearance in the future.

Such fear was jointly expressed by the World Health Organization (WHO) and research scientists of large pharmaceutical firms in the wake of the global spread of AH1N1 that has killed more than 80 people worldwide.

ABS-CBN Europe News Bureau exclusively interviewed Philippine Ambassador to Switzerland Ma. Theresa Lazaro shortly after her closed-door meeting with Dr. Severin Schwan, chief executive officer of Roche Group in Basel.

Roche is the leading manufacturer of the anti-viral drug Tamiflu.

While Roche admits there is sufficient supply of Tamiflu following an AH1N1 pandemic, Dr. Schwan is bothered if such drug can cure a possible mutation of the flu virus.

"Ano ang susunod dito? Ano ang mutation or possible mutation? Ano ang possible na mangyari doon sa virus na ito na predicted ng WHO at ng mga scientists ng Roche na may konting peligroso,” Lazaro said.

Dr. Schwan said there was also an influenza outbreak in the United States last year that has direct correlation with the AH1N1, but this did not reach the pandemic stage.

Switzerland is one of the 40 countries with confirmed AH1N1 cases. With ANC's On the Scene